EphrinB2-EphB4-RASA1 Signaling in Human Cerebrovascular Development and Disease

Trends Mol Med. 2019 Apr;25(4):265-286. doi: 10.1016/j.molmed.2019.01.009. Epub 2019 Feb 25.

Abstract

Recent whole exome sequencing studies in humans have provided novel insight into the importance of the ephrinB2-EphB4-RASA1 signaling axis in cerebrovascular development, corroborating and extending previous work in model systems. Here, we aim to review the human cerebrovascular phenotypes associated with ephrinB2-EphB4-RASA1 mutations, including those recently discovered in Vein of Galen malformation: the most common and severe brain arteriovenous malformation in neonates. We will also discuss emerging paradigms of the molecular and cellular pathophysiology of disease-causing ephrinB2-EphB4-RASA1 mutations, including the potential role of somatic mosaicism. These observations have potential diagnostic and therapeutic implications for patients with rare congenital cerebrovascular diseases and their families.

Keywords: Vein of Galen malformation; arteriovenous malformation; cerebrovascular disorders; ephrin signaling; neurosurgery; vasculogenesis.

Publication types

  • Review

MeSH terms

  • Animals
  • Cerebrovascular Disorders / etiology*
  • Cerebrovascular Disorders / metabolism*
  • Cerebrovascular Disorders / pathology
  • Disease Susceptibility
  • Ephrin-B2 / chemistry
  • Ephrin-B2 / genetics
  • Ephrin-B2 / metabolism*
  • Genetic Predisposition to Disease
  • Humans
  • Neovascularization, Physiologic*
  • Receptor, EphB4 / chemistry
  • Receptor, EphB4 / genetics
  • Receptor, EphB4 / metabolism*
  • Signal Transduction*
  • Structure-Activity Relationship
  • p120 GTPase Activating Protein / chemistry
  • p120 GTPase Activating Protein / genetics
  • p120 GTPase Activating Protein / metabolism*

Substances

  • EFNB2 protein, human
  • EPHB4 protein, human
  • Ephrin-B2
  • RASA1 protein, human
  • p120 GTPase Activating Protein
  • Receptor, EphB4